← Browse by Condition
Medical Condition

smoldering systemic mastocytosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT04910685 Phase 2, Phase 3
Recruiting

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Enrollment
534 pts
Location
United States, Austr...
Sponsor
Blueprint Medicines Corporatio...
View Trial →